dr. E.W. Duiker

dr. E.W. Duiker
E-mail:
e.w.duiker umcg.nl

Research

  1. 2018
  2. Caumanns, J. J., Berns, K., Wisman, G. B. A., Fehrmann, R. S. N., Tomar, T., Klip, H., Meersma, G. J., Hijmans, E. M., Gennissen, A., Duiker, E. W., Weening, D., Itamochi, H., Kluin, R. J., Reyners, A. K. L., Birrer, M. J., Salvesen, H. B., Vergote, I., Van Nieuwenhuysen, E., Brenton, J. D., ... de Jong, S. (2018). Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma. Clinical Cancer Research, 24(16), 3928-3940. https://doi.org/10.1158/1078-0432.CCR-17-3060
  3. 2016
  4. 2015
  5. 2012
  6. 2011
  7. Duiker, E. W., de Vries, E., Mahalingam, D., Meersma, G. J., Lub-de Hooge, M. N., Cool, R. H., Quax, W. J., Samali, A., van der Zee, A. G. J., & de Jong, S. (2011). ENHANCED ANTI-TUMOR EFFICACY OF A DR5-SPECIFIC TRAIL VARIANT OVER RHTRAIL IN A BIOLUMINESCENT OVARIAN CANCER XENOGRAFT MODEL. In D. Wallach, A. Kovalenko, & M. Feldman (Eds.), ADVANCES IN TNF FAMILY RESEARCH (pp. 796-797). (Advances in Experimental Medicine and Biology; Vol. 691). Springer.
  8. 2010
  9. 2009
  10. 2008
  11. 2006

ID: 233048